Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma

The incidence of human malignant pleural mesothelioma (hMPM) is still increasing worldwide. hMPM prognosis is poor even if the median survival time has been slightly improved after the introduction of the up-to-date chemotherapy. Nevertheless, large phase II/III trials support the combination of pla...

Full description

Saved in:
Bibliographic Details
Main Authors: Favoni, Roberto E, Daga, Antonio, Malatesta, Paolo, Florio, Tullio
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2012
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3417486/
https://ncbi.nlm.nih.gov/pubmed/22289125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2012.01873.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items